Design, synthesis and biological evaluation of some isatin-linked chalcones as novel anti-breast cancer agents: A molecular hybridization approach

Chandrabose Karthikeyan , Viswas Raja Solomon , Hoyun Lee , Piyush Trivedi
{"title":"Design, synthesis and biological evaluation of some isatin-linked chalcones as novel anti-breast cancer agents: A molecular hybridization approach","authors":"Chandrabose Karthikeyan ,&nbsp;Viswas Raja Solomon ,&nbsp;Hoyun Lee ,&nbsp;Piyush Trivedi","doi":"10.1016/j.bionut.2013.04.001","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span>Isatins are endogenous molecules present in human and mammals which exhibits diverse pharmacological profiles including </span>anticancer activity. Similarly, </span>chalcones<span>, which are common substructures in numerous natural products belonging to the flavonoid<span> family, show potent anticancer properties. A novel series of 3-(2-oxo-2-phenylethylidene)indolin-2-ones incorporating pharmacophoric elements of isatins and chalcones were designed and synthesized. The compounds were evaluated for anticancer activity against three breast cancer cell lines. Most of the compounds showed promising anticancer activity (&lt;</span></span></span> <!-->20<!--> <!-->μM) against the studied cell lines. Compound <strong>2c</strong>, bearing a 5-chloro substituent in the benzo ring of the isatin moiety and 3,4-dimethoxy substitutions in the phenyl ring, was found to be the most active in the series with GI<sub>50</sub><span> values of 8.54, 4.76 and 3.59 against MDA-MB231, MDA-MB468 and MCF7 cells, respectively. Overall, the findings of the study highlight 3-(2-oxo-2-phenylethylidene)indolin-2-one as a potential new lead in the search of drugs<span> for the treatment of breast cancer.</span></span></p></div>","PeriodicalId":100182,"journal":{"name":"Biomedicine & Preventive Nutrition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionut.2013.04.001","citationCount":"47","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Preventive Nutrition","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210523913000251","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 47

Abstract

Isatins are endogenous molecules present in human and mammals which exhibits diverse pharmacological profiles including anticancer activity. Similarly, chalcones, which are common substructures in numerous natural products belonging to the flavonoid family, show potent anticancer properties. A novel series of 3-(2-oxo-2-phenylethylidene)indolin-2-ones incorporating pharmacophoric elements of isatins and chalcones were designed and synthesized. The compounds were evaluated for anticancer activity against three breast cancer cell lines. Most of the compounds showed promising anticancer activity (< 20 μM) against the studied cell lines. Compound 2c, bearing a 5-chloro substituent in the benzo ring of the isatin moiety and 3,4-dimethoxy substitutions in the phenyl ring, was found to be the most active in the series with GI50 values of 8.54, 4.76 and 3.59 against MDA-MB231, MDA-MB468 and MCF7 cells, respectively. Overall, the findings of the study highlight 3-(2-oxo-2-phenylethylidene)indolin-2-one as a potential new lead in the search of drugs for the treatment of breast cancer.

一些isatin-linked chalcones作为新型抗乳腺癌药物的设计、合成和生物学评价:分子杂交方法
Isatins是存在于人类和哺乳动物体内的内源性分子,具有多种药理特征,包括抗癌活性。类似地,查尔酮是许多天然产物中常见的亚结构,属于类黄酮家族,显示出有效的抗癌特性。设计并合成了一种新的3-(2-氧-2-苯基乙基)吲哚-2-酮类化合物,该化合物含有鸢尾素和查尔酮的药效成分。这些化合物对三种乳腺癌细胞系的抗癌活性进行了评估。大多数化合物显示出良好的抗癌活性(<20 μM)。化合物2c对MDA-MB231、MDA-MB468和MCF7细胞的GI50值分别为8.54、4.76和3.59,是该系列中活性最高的化合物,其isatin部分的苯环上有一个5-氯取代,苯基环上有3,4-二甲氧基取代。总的来说,这项研究的发现突出了3-(2-氧-2-苯基乙基)吲哚-2- 1作为寻找治疗乳腺癌药物的潜在新先导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信